Understanding carcinogenesis for fighting oral cancer

Journal of Oncology

Volumn , Issue , 2011, Pages

  Tanaka, Takuji ^a,b   Ishigamori, Rikako ^c  

^a TCI CaRP   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; ALPHA TOCOPHEROL; BIOLOGICAL MARKER; BOWMAN BIRK INHIBITOR; CURCUMIN; CYCLOOXYGENASE 2 INHIBITOR; CYTOCHROME P450 1A1; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EPIGALLOCATECHIN GALLATE; ISOTRETINOIN; KETOROLAC; PLACEBO; PROTEIN BCL 2; RETINOIC ACID RECEPTOR BETA; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR AP 1;

ANEUPLOIDY; CANCER MODEL; CANCER PREVENTION; CANCER RISK; CARCINOGENESIS; CELL PROLIFERATION; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG TOXICITY; DYSPLASIA; EARLY DIAGNOSIS; ERYTHROPLASIA; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; LEUKOPLAKIA; MALIGNANT TRANSFORMATION; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; MOUTH CANCER; MOUTH CARCINOMA; MOUTH MUCOSA; NONHUMAN; OXIDATIVE STRESS; PATIENT MONITORING; PHARMACOGENOMICS; PRECANCER; PROTEIN TARGETING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SISTER CHROMATID EXCHANGE; SMOKING; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; STOMATITIS; TOBACCO; WART VIRUS;

EID: 79959223778     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2011/603740     Document Type: Review

References (102)

1. Williams H. K., Molecular pathogenesis of oral squamous carcinoma Molecular Pathology 2000 53 4 165 172 (Pubitemid 30603069)
2. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M. J., Cancer statistics, 2009 CA Cancer Journal for Clinicians 2009 59 4 225 249
3. Parkin D. M., Laara E., Muir C. S., Estimates of the worldwide frequency of sixteen major cancers in 1980 International Journal of Cancer 1988 41 2 184 197 (Pubitemid 18061141)
4. Matsuda T., Marugame T., Kamo K. I., Katanoda K., Ajiki W., Sobue T., Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project Japanese Journal of Clinical Oncology 2009 39 12 850 858
5. Boffetta P., Hecht S., Gray N., Gupta P., Straif K., Smokeless tobacco and cancer The Lancet Oncology 2008 9 7 667 675 (Pubitemid 351878052)
6. Gillenwater A., Papadimitrakopoulou V., Richards-Kortum R., Oral premalignancy: new methods of detection and treatment Current Oncology Reports 2006 8 2 146 154
7. Petersen P. E., Oral cancer prevention and controlthe approach of the World Health Organization Oral Oncology 2009 45 4-5 454 460
8. Tanaka T., Chemoprevention of oral carcinogenesis European Journal of Cancer Part B 1995 31 1 3 15
9. Tanaka T., Effect of diet on human carcinogenesis Critical Reviews in Oncology/Hematology 1997 25 2 73 95 (Pubitemid 27168182)
10. Tanaka T., Chemoprevention of human cancer: biology and therapy Critical Reviews in Oncology/Hematology 1997 25 3 139 174 (Pubitemid 27240179)
11. Joseph B. K., Oral cancer: prevention and detection Medical Principles and Practice 2002 11 1 32 35 (Pubitemid 34507647)
12. Campo-Trapero J., Cano-Snchez J., Palacios-Snchez B., Snchez-Gutierrez J. J., Gonzlez-Moles M. A., Bascones-Martnez A., Update on molecular pathology in oral cancer and precancer Anticancer Research 2008 28 2B 1197 1205 (Pubitemid 351578858)
13. Patel V., Leethanakul C., Gutkind J. S., New approaches to the understanding of the molecular basis of oral cancer Critical Reviews in Oral Biology and Medicine 2001 12 1 55 63 (Pubitemid 32374284)
14. Tsantoulis P. K., Kastrinakis N. G., Tourvas A. D., Laskaris G., Gorgoulis V. G., Advances in the biology of oral cancer Oral Oncology 2007 43 6 523 534 (Pubitemid 46860349)
15. Viet C. T., Schmidt B. L., Understanding oral cancer in the genome era Head and Neck 2010 32 9 1246 1268
16. Slaughter D. P., Southwick H. W., Smejkal W., Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 1953 6 5 963 968
17. Willis R. A., Further studies on the mode of origin of carcinomas of the skin Cancer Research 1945 5 469 479
18. Boyle J. O., Hakim J., Koch W., Van der Riet P., Hruban R. H., Roa R. A., Correo R., Eby Y. J., Ruppert J. M., Sidransky D., The incidence of p53 mutations increases with progression of head and neck cancer Cancer Research 1993 53 18 4477 4480 (Pubitemid 23304366)
19. Brennan J. A., Boyle J. O., Koch W. M., Goodman S. N., Hruban R. H., Eby Y. J., Couch M. J., Forastiere A. A., Sidransky D., Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck New England Journal of Medicine 1995 332 11 712 717
20. Braakhuis B. J. M., Tabor M. P., Kummer J. A., Leemans C. R., Brakenhoff R. H., A genetic explanation of slaughter's concept of field cancerization: evidence and clinical implications Cancer Research 2003 63 8 1727 1730 (Pubitemid 36460827)
21. Warnakulasuriya S., Sutherland G., Scully C., Tobacco, oral cancer, and treatment of dependence Oral Oncology 2005 41 3 244 260 (Pubitemid 40311753)
22. Ogden G. R., Alcohol and oral cancer Alcohol 2005 35 3 169 173 (Pubitemid 41079920)
23. Jeng J. H., Chang M. C., Hahn L. J., Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives Oral Oncology 2001 37 6 477 492 (Pubitemid 32588773)
24. Goldstein A. M., Blot W. J., Greenberg R. S., Schoenberg J. B., Austin D. F., Preston-Martin S., Winn D. M., Bernstein L., McLaughlin J. K., Fraumeni J. F., Familial risk in oral and pharyngeal cancer European Journal of Cancer Part B 1994 30 5 319 322 (Pubitemid 24309212)
25. Foulkes W. D., Brunet J. S., Sieh W., Black M. J., Shenouda G., Narod S. A., Familial risks of squamous cel carcinoma of the head and neck: retrospective case-control study British Medical Journal 1996 313 7059 716 721 (Pubitemid 26313071)
26. Ankathil R., Mathew A., Joseph F., Nair M. K., Is oral cancer susceptibility inherited? Report of five oral cancer families European Journal of Cancer Part B 1996 32 1 63 67
27. Sato M., Sato T., Izumo T., Amagasa T., Genetic polymorphism of drug-metabolizing enzymes and susceptibility to oral cancer Carcinogenesis 1999 20 10 1927 1931 (Pubitemid 29476118)
28. Sreelekha T. T., Ramadas K., Pandey M., Thomas G., Nalinakumari K. R., Pillai M. R., Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer Oral Oncology 2001 37 7 593 598 (Pubitemid 32889622)
29. Gonzlez M. V., Alvarez V., Pello M. F., Menndez M. J., Surez C., Coto E., Genetic polymorphism of N-acetyltransferase-2, glutathione S- transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer Journal of Clinical Pathology 1998 51 4 294 298 (Pubitemid 28280999)
30. Harty L. C., Caporaso N. E., Hayes R. B., Winn D. M., Bravo-Otero E., Blot W. J., Kleinman D. V., Brown L. M., Armenian H. K., Fraumeni J. F., Shields P. G., Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers Journal of the National Cancer Institute 1997 89 22 1698 1705 (Pubitemid 27508194)
31. Brennan P., Lewis S., Hashibe M., Bell D. A., Boffetta P., Bouchardy C., Caporaso N., Coutelle C., Diehl S. R., Hayes R. B., Olshan A. F., Schwartzs S. M., Sturgis E. M., Wei Q., Zavras A. I., Benhamou S., Pooled analysis of alcohol dehydrogenase genotypes and head and neck cancer: a HuGE review American Journal of Epidemiology 2004 159 1 1 16 (Pubitemid 38049416)
32. Braakhuis B. J. M., Snijders P. J. F., Keune W. J. H., Meijer C. J. L. M., Ruijter-Schippers H. J., Leemans C. R., Brakenhoff R. H., Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus Journal of the National Cancer Institute 2004 96 13 998 1006 (Pubitemid 39162642)
33. Mao LI., Hong W. K., How does human papillomavirus contribute to head and neck cancer development? Journal of the National Cancer Institute 2004 96 13 978 979 (Pubitemid 39162631)
34. Ang K. K., Harris J., Wheeler R., Weber R., Rosenthal D. I., Nguyen-Tn P. F., Westra W. H., Chung C. H., Jordan R. C., Lu C., Kim H., Axelrod R., Silverman C. C., Redmond K. P., Gillison M. L., Human papillomavirus and survival of patients with oropharyngeal cancer New England Journal of Medicine 2010 363 1 24 35
35. Hooper S. J., Wilson M. J., Crean S. J., Exploring the link between microorganisms and oral cancer: a systematic review of the literature Head and Neck 2009 31 9 1228 1239
36. Meurman J. H., Uittamo J., Oral micro-organisms in the etiology of cancer Acta Odontologica Scandinavica 2008 66 6 321 326
37. Neville B. W., Day T. A., Oral cancer and precancerous lesions Ca-A Cancer Journal for Clinicians 2002 52 4 195 215
38. Schwimmer E., Die idiopathischen Schleimhautplaques der Mundhhle (Leukoplakia buccalis) Arch. Dermat. Syph. 1877 9 570 611
39. Kramer I. R. H., Lucas R. B., Pindborg J. J., Definition of leukoplakia and related lesions: an aid to studies on oral precancer Oral Surgery Oral Medicine and Oral Pathology 1978 46 4 518 539 (Pubitemid 9056118)
40. Bouquot J. E., Gorlin R. J., Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years Oral Surgery Oral Medicine and Oral Pathology 1986 61 4 373 381 (Pubitemid 16109114)
41. Waldron C. A., Shafer W. G., Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias Cancer 1975 36 4 1386 1392
42. Queyrat L., Erythroplasie de gland Bull Soc. Bull. Franc. Derm. Syph. 1911 22 378 382
43. Ferrari D., Codec C., Fiore J., Moneghini L., Bosari S., Foa P., Biomolecular markers in cancer of the tongue Journal of Oncology 2009 2009 11
44. Day G. L., Blot W. J., Austin D. F., Bernstein L., Greenberg R. S., Preston-Martin S., Schoenberg J. B., Winn D. M., McLaughlin J. K., Fraumeni J. F., Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants Journal of the National Cancer Institute 1993 85 6 465 473 (Pubitemid 23084091)
45. McKeown-Eyssen G., Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiology Biomarkers and Prevention 1994 3 8 687 695 (Pubitemid 24377963)
46. Rothman N., Stewart W. F., Schulte P. A., Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories Cancer Epidemiology Biomarkers and Prevention 1995 4 4 301 311
47. Perera F. P., Weinstein I. B., Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation Journal of Chronic Diseases 1982 35 7 581 600 (Pubitemid 12085585)
48. Stich H. F., Hornby A. P., Dunn B. P., A pilot beta-carotene intervention trial with inuits using smokeless tobacco International Journal of Cancer 1985 36 3 321 327 (Pubitemid 16250994)
49. Stich H. F., Rosin M. P., Hornby A. P., Mathew B., Sankaranarayanan R., Nair M. K., Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A International Journal of Cancer 1988 42 2 195 199
50. Benner S. E., Wargovich M. J., Lippman S. M., Fisher R., Velasco M., Winn R. J., Hong W. K., Reduction in oral mucosa micronuclei frequency following alpha-tocopherol treatment of oral leukoplakia Cancer Epidemiology Biomarkers and Prevention 1994 3 1 73 76 (Pubitemid 24172526)
51. Scully C., Sudb J., Speight P. M., Progress in determining the malignant potential of oral lesions Journal of Oral Pathology and Medicine 2003 32 5 251 256 (Pubitemid 36565641)
52. Lee J. J., Hong W. K., Hittelman W. N., Mao LI., Lotan R., Shin D. M., Benner S. E., Xu X. C., Lee J. S., Papadimitrakopoulou V. M., Geyer C., Perez C., Martin J. W., El-Naggar A. K., Lippman S. M., Predicting cancer development in oral leukoplakia: ten years of translational research Clinical Cancer Research 2000 6 5 1702 1710 (Pubitemid 30305062)
53. Kanojia D., Vaidya M. M., 4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis Oral Oncology 2006 42 7 655 667 (Pubitemid 44094232)
54. Schwartz J. L., Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis Critical Reviews in Oral Biology and Medicine 2000 11 1 92 122 (Pubitemid 30080933)
55. Vairaktaris E., Spyridonidou S., Papakosta V., Vylliotis A., Lazaris A., Perrea D., Yapijakis C., Patsouris E., The hamster model of sequential oral oncogenesis Oral Oncology 2008 44 4 315 324 (Pubitemid 351380986)
56. Vitale-Cross L., Czerninski R., Amornphimoltham P., Patel V., Molinolo A. A., Gutkind J. S., Chemical carcinogenesis models for evaluating molecular-targeted prevention and treatment of oral cancer Cancer Prevention Research 2009 2 5 419 422
57. Gimenez-Conti I. B., Slaga T. J., The hamster cheek pouch carcinogenesis model Journal of Cellular Biochemistry 1993 52 83 90 (Pubitemid 23252925)
58. Tanaka T., Kojima T., Okumura A., Yoshimi N., Mori H., Alterations of the nucleolar organizer regions during 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats Carcinogenesis 1991 12 2 329 333
59. Vered M., Yarom N., Dayan D., 4NQO oral carcinogenesis: animal models, molecular markers and future expectations Oral Oncology 2005 41 4 337 339 (Pubitemid 40387861)
60. Schwartz J. L., Sloane D., Shklar G., Prevention and inhibition of oral cancer in the hamster buccal pouch model associated with carotenoid immune enhancement Tumor Biology 1989 10 6 297 309 (Pubitemid 20043086)
61. Tanaka T., Kawabata K., Kakumoto M., Matsunaga K., Mori H., Murakami A., Kuki W., Takahashi Y., Yonei H., Satoh K., Hara A., Maeda M., Ota T., Odashima S., Koshimizu K., Ohigashi H., Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by citrus auraptene in rats Carcinogenesis 1998 19 3 425 431 (Pubitemid 28375444)
62. Tanaka T., Kawabata K., Kohno H., Honjo S., Murakami M., Ota T., Tsuda H., Chemopreventive effect of bovine lactoferrin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats Japanese Journal of Cancer Research 2000 91 1 25 33 (Pubitemid 30128934)
63. Tanaka T., Kawamori T., Ohnishi M., Okamoto K., Mori H., Hara A., Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary protocatechuic acid during initiation and postinitiation phases Cancer Research 1994 54 9 2359 2365 (Pubitemid 24138725)
64. Tanaka T., Kohno H., Nomura E., Taniguchi H., Tsuno T., Tsuda H., A novel geranylated derivative, ethyl 3-(4′-geranyloxy-3′-methoxyphenyl)-2- propenoate, synthesized from ferulic acid suppresses carcinogenesis and inducible nitric oxide synthase in rat tongue Oncology 2003 64 2 166 175 (Pubitemid 36173383)
65. Tanaka T., Kohno H., Sakata K., Yamada Y., Hirose Y., Sugie S., Mori H., Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis Carcinogenesis 2002 23 8 1361 1367
66. Tanaka T., Kojima T., Hara A., Sawada H., Mori H., Chemoprevention of oral carcinogenesis by DL- -difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4- nitroquinoline 1-oxide-induced tongue neoplasms in rats Cancer Research 1993 53 4 772 776 (Pubitemid 23077860)
67. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H., Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids Carcinogenesis 1993 14 7 1321 1325 (Pubitemid 23229674)
68. Tanaka T., Kojima T., Morishita Y., Mori H., Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis Japanese Journal of Cancer Research 1992 83 8 835 842
69. Tanaka T., Kuniyasu T., Shima H., Carcinogenicity of betel quid. III. Enhancement of 4-nitroquinoline-1-oxide- and N-2-fluorenylacetamide-induced carcinogenesis in rats by subsequent administration of betel nut Journal of the National Cancer Institute 1986 77 3 777 781 (Pubitemid 16016597)
70. Tanaka T., Makita H., Kawabata K., Mori H., El-Bayoumy K., 1,4-phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis Cancer Research 1997 57 17 3644 3648 (Pubitemid 27381199)
71. Tanaka T., Makita H., Ohnishi M., Hirose Y., Wang A., Mori H., Satoh K., Hara A., Ogawa H., Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of -carotene Cancer Research 1994 54 17 4653 4659
72. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A., Inhibition of oral carcinogenesis by the arotinoid mofarotene (Ro 40-8757) in male F344 rats Carcinogenesis 1995 16 8 1903 1907
73. Tanaka T., Makita H., Ohnishi M., Mori H., Satoh K., Hara A., Sumida T., Fukutani K., Tanaka T., Ogawa H., Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination Cancer Research 1997 57 2 246 252 (Pubitemid 27036601)
74. Tanaka T., Nishikawa A., Mori Y., Morishita Y., Mori H., Inhibitory effects of non-steroidal anti-inflammatory drugs, piroxicam and indomethacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male ACI/N rats Cancer Letters 1989 48 3 177 182 (Pubitemid 20009040)
75. Hawkins B. L., Heniford B. W., Ackermann D. M., Leonberger M., Martinez S. A., Hendler F. J., 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma Head and Neck 1994 16 5 424 432 (Pubitemid 24262590)
76. Kawabata K., Tanaka T., Honjo S., Kakumoto M., Hara A., Makita H., Tatematsu N., Ushida J., Tsuda H., Mori H., Chemopreventive effect of dietary flavonoid morin on chemically induced rat tongue carcinogenesis International Journal of Cancer 1999 83 3 381 386 (Pubitemid 29455762)
77. Makita H., Mutoh M., Maruyama T., Yonemoto K., Kobayashi A., Fujitsuka H., Toida M., Shibata T., Miyamoto S., Yasui Y., Suzuki R., Wakabayashi K., Tanaka T., A prostaglandin E receptor subtype EP-selective antagonist, ONO-8711, suppresses 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis Carcinogenesis 2007 28 3 677 684 (Pubitemid 46523364)
78. Makita H., Tanaka T., Fujitsuka H., Tatematsu N., Satoh K., Hara A., Mori H., Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin Cancer Research 1996 56 21 4904 4909 (Pubitemid 26374427)
79. Makita H., Tanaka T., Ohnishi M., Tamai Y., Torihara M., Yamahara J., Mori H., Satoh K., Hara A., Inhibition of 4-nitroquinoline-1-oxide-induced rat oral carcinogenesis by dietary exposure of a new retinoidal butenolide, KYN-54, during the initiation and post-initiation phases Carcinogenesis 1995 16 9 2171 2176
80. Ohnishi M., Tanaka T., Makita H., Kawamori T., Mori H., Satoh K., Hara A., Murakami A., Ohigashi H., Koshimizu K., Chemopreventive effect of a xanthine oxidase inhibitor, 1′-acetoxychavicol acetate, on rat oral carcinogenesis Japanese Journal of Cancer Research 1996 87 4 349 356
81. Suzuki R., Kohno H., Sugie S., Tanaka T., Dietary protocatechuic acid during the progression phase exerts chemopreventive effects on chemically induced rat tongue carcinogenesis Asian Pacific Journal of Cancer Prevention 2003 4 4 319 326
82. Yanaida Y., Kohno H., Yoshida K., Hirose Y., Yamada Y., Mori H., Tanaka T., Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats Carcinogenesis 2002 23 5 787 794 (Pubitemid 34567517)
83. Yoshida K., Hirose Y., Tanaka T., Yamada Y., Kuno T., Kohno H., Katayama M., Qiao Z., Sakata K., Sugie S., Shibata T., Mori H., Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide Cancer Science 2003 94 4 365 371 (Pubitemid 36626370)
84. Yoshida K., Tanaka T., Hirose Y., Yamaguchi F., Kohno H., Toida M., Hara A., Sugie S., Shibata T., Mori H., Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats Cancer Letters 2005 221 1 29 39 (Pubitemid 40387906)
85. Hursting S. D., Perkins S. N., Haines D. C., Ward J. M., Phang J. M., Chemoprevention of spontaneous tumorigenesis in p53-knockout mice Cancer Research 1995 55 18 3949 3953
86. Miyamoto S., Yasui Y., Kim M., Sugie S., Murakami A., Ishigamori-Suzuki R., Tanaka T., A novel ras H2 mouse carcinogenesis model that is highly susceptible to 4-NQO-induced tongue and esophageal carcinogenesis is useful for preclinical chemoprevention studies Carcinogenesis 2008 29 2 418 426 (Pubitemid 351359683)
87. Suzuki R., Kohno H., Suzui M., Yoshimi N., Tsuda H., Wakabayashi K., Tanaka T., An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies Carcinogenesis 2006 27 3 619 630 (Pubitemid 43372890)
88. Hong W. K., Endicott J., Itri L. M., 13-cis-retinoic acid in the treatment of oral leukoplakia New England Journal of Medicine 1986 315 24 1501 1505 (Pubitemid 17052146)
89. Papadimitrakopoulou V. A., Hong W. K., Lee J. S., Martin J. W., Lee J. J., Batsakis J. G., Lippman S. M., Low-dose isotretinoin versus -carotene to prevent oral carcinogenesis: long-term follow-up Journal of the National Cancer Institute 1997 89 3 257 258 (Pubitemid 27073764)
90. Mao L., El-Naggar A. K., Papadimitrakopoulou V., Shin D. M., Shin H. C., Fan Y., Zhou X., Clayman G., Lee J. J., Lee J. S., Hittelman W. N., Lippman S. M., Hong W. K., Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy Journal of the National Cancer Institute 1998 90 20 1545 1551 (Pubitemid 28535719)
91. Armstrong W. B., Kennedy A. R., Wan X. S., Taylor T. H., Nguyen Q. A., Jensen J., Thompson W., Lagerberg W., Meyskens F. L., Clinical modulation of oral leukoplakia and protease activity by Bowman-Birk inhibitor concentrate in a phase IIa chemoprevention trial Clinical Cancer Research 2000 6 12 4684 4691 (Pubitemid 32110405)
92. Chen A.-L., Hsu C.-H., Lin J.-K., Hsu M. -M., Ho Y. -F., She T. -S., Ko J. -Y., Lin J. -T., Lin B. -R., Wu M. -S., Yu H. -S., Jee S. -H., Chen G. -S., Chen T. -M., Chen C. -A., Lai M. -K., Pu Y. -S., Pan M. -H., Wang Y. -J., Tsai C. -C., Hsieh C. -Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Research 2001 21 4B 2895 2900 (Pubitemid 33051148)
93. Zhang X., Chen Z., Choe M. S., Lin Y., Sun S. Y., Wieand H. S., Shin H. J. C., Chen A., Khuri F. R., Shin D. M., Tumor growth inhibition by simultaneously blocking epidermal growth factor receptor and cyclooxygenase-2 in a xenograft model Clinical Cancer Research 2005 11 17 6261 6269 (Pubitemid 41262957)
94. Rhee J. C., Khuri F. R., Shin D. M., Advances in chemoprevention of head and neck cancer Oncologist 2004 9 3 302 311 (Pubitemid 38756878)
95. Lippman S. M., Gibson N., Subbaramaiah K., Dannenberg A. J., Combined targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways Clinical Cancer Research 2005 11 17 6097 6099 (Pubitemid 41262933)
96. Chan G., Boyle J. O., Yang E. K., Zhang F., Sacks P. G., Shah J. P., Edelstein D., Soslow R. A., Koki A. T., Woerner B. M., Masferrer J. L., Dannenberg A. J., Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck Cancer Research 1999 59 5 991 994 (Pubitemid 29135955)
97. Nishimura N., Urade M., Hashitani S., Noguchi K., Manno Y., Takaoka K., Sakurai K., Increased expression of cyclooxygenase (COX)-2 in DMBA-induced hamster cheek pouch carcinogenesis and chemopreventive effect of a selective COX-2 inhibitor celecoxib Journal of Oral Pathology and Medicine 2004 33 10 614 621 (Pubitemid 39468932)
98. Mulshine J. L., Atkinson J. C., Greer R. O., Papadimitrakopoulou V. A., Van Waes C., Rudy S., Martin J. W., Steinberg S. M., Liewehr D. J., Avis I., Linnoila R. I., Hewitt S., Lippman S. M., Frye R., Cavanaugh P. F., Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia Clinical Cancer Research 2004 10 5 1565 1573 (Pubitemid 38435544)
99. Shin D. M., Ro J. Y., Hong W. K., Hittelman W. N., Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis Cancer Research 1994 54 12 3153 3159 (Pubitemid 24208920)
100. Dassonville O., Formento J. L., Francoual M., Ramaioli A., Santini J., Schneider M., Demard F., Milano G., Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer Journal of Clinical Oncology 1993 11 10 1873 1878 (Pubitemid 23304610)
101. Pomerantz R. G., Grandis J. R., The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy Seminars in Oncology 2004 31 6 734 743 (Pubitemid 39602679)
102. Choe M. S., Zhang X., Shin H. J. C., Shin D. M., Zhuo C., Interaction between epidermal growth factor receptor- and cyclooxygenase 2-mediated pathways and its implications for the chemoprevention of head and neck cancer Molecular Cancer Therapeutics 2005 4 9 1448 1455